Phio Pharmaceuticals Corp.

PHIO

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001533040

SEC filings (opens in a new tab)

In the last 90 days, Phio Pharmaceuticals Corp. insiders filed 5 open-market purchases and 0 sales; 24 institutions reported holding it in 13F filings for Q2 2026, worth $662.6K in total; no superinvestor holds it.

Q3 2023 vs. Q2 2023

How the institutions holding Phio Pharmaceuticals Corp. changed between Q2 2023 and Q3 2023.

All holders in Q3 2023 All holders in Q2 2023

13F holders of PHIO: Q2 2023 compared with Q3 2023
Measure	Q2 2023	Q3 2023	Change
Holders	13	14	+1
Shares	274.8K	286.8K	+12.0K (+4.4%)
Value	$798.3K	$445.4K	−$352.9K (−44.2%)

New holders (2)

Institutions that held Phio Pharmaceuticals Corp. at the end of Q3 2023 but not at the end of Q2 2023.

Institutions new to PHIO in Q3 2023
Institution	Shares	Value	% of portfolio
Geode Capital Management, LLC	15,229	$22.8K	0.00%
Citigroup Inc	917	$1.38K	0.00%

Sold out (1)

Institutions that held Phio Pharmaceuticals Corp. at the end of Q2 2023 and filed for Q3 2023 without it.

Institutions that sold out of PHIO in Q3 2023
Institution	Shares, Q2 2023	Value, Q2 2023
Anson Funds Management LP	22,571	$64.8K